Arotech Corp. (ARTX) Posts Weakened Q4 Results
Arotech Corp. (NASDAQ: ARTX) reported Q4 EPS of ($0.03), versus $0.06 last year. Revenue for the quarter came in at $17.3 million, versus $20.86 million last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Murphy Oil (MUR) Tops Q3 EPS by 2c; Guides Q4, FY16 Production
- Universal Health (UHS) Misses Q3 EPS by 8c, Updates FY Guidance
- CryoLife (CRY) Tops Q3 EPS by 8c, Boosts FY Guidance
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!